2[2]Dietz HC,McIntosh I,Sakai LY,et al.Four novel FBN1 mutations:significance for mutant transcript level and EGF like domain calcium binding in the pathogenesis of Marfan syndrome[J].Genomics,1993,17(2):468-475.
3[3]Robinson PN,Booms P.The molecular pathogenesis of the Marfan syndrome[J].Cell Mol Life Sci,2001,58 (11):1698-1707.
4[4]Ng CM,Cheng A,Myers LA,et al.TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome[J].J Clin Invest,2004,114(11):1586-1592.
5[5]Giusti B,Marcucci R,Lapini I,et al.Role of hyperhomocysteinemia in aortic disease[J].Cell Mol Biol Noisy-legrand),2004,50(8):945-952.
6[6]Iwasaki T,Iwasaki T,Aihara Y,et al.Immunoscintigraphy of aortic dissection with 99mTc-labeled murine anti-smooth muscle myosin monoclonal antibody in rats[J].J Nucl Med,2001,42(1):130-137.
7[7]Okura T,Nakamura M,Takata Y,et al.Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells[J].Eur J Pharmacol,2000,407 (3):227-235.
8[8]Sakomura Y,Nagashima H,Aoka Y,et al.Expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells is upregulated in cystic[J].Circulation,2002,106(12 Suppl 1):1259-1263.
